Financial Times: US investors are pushing Asian fund managers to create special vehicles so they can invest in Asia while avoiding US investment restrictions on Chinese tech — Institutional clients increasingly want so-called parallel funds that exclude cer…
ULTA — 6.4 Hold. The quarter was actually good on the surface: +5.8% comps, $3.90B revenue beating estimates, record 46.7M loyalty members. The market didn't care. SG&A jumped 23% to 25.7% of sales — up 230 bps year over year — and operating income fell 7.9% on 11.8% revenue growth.
Health Catalyst (NASDAQ:HCAT – Get Free Report) released its earnings results on Thursday. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02), FiscalAI reports. The firm had revenue of $74.68 million for the quarter, compared to the
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.08, FiscalAI reports. Allogene Therapeutics Trading Down 6.1% Shares of NASDAQ ALLO traded down $0.
Clearmind Medicine (NASDAQ:CMND – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($3.32) earnings per share (EPS) for the quarter, FiscalAI reports. Clearmind Medicine Stock Down 11.6% Clearmind Medicine stock traded down $0.11 during mid-day trading on Thursday, hitting $0.83. 146,
